GliaSite 1-3 Mets Study

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2008

Conditions
Brain Metastases
Interventions
DEVICE

GliaSite Radiation Therapy System

GliaSite RTS is designed to deliver intracavitary radiation therapy for brain tumors. Following surgical resection, the balloon catheter is inflated to fill the cavity and Iotrex radiotherapy solution infused. It is a single applicator system that provides a uniform and conformal dose to the resection cavity.

Trial Locations (1)

38104

Methodist University Hospital, Memphis

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Methodist Healthcare

OTHER

lead

Hologic, Inc.

INDUSTRY